0388.HK (0388.HK)

$483.4B
Market Cap
27.3
P/E Ratio
0.96
Beta
3.34%
Dividend Yield
Piotroski 5/9Altman Z 0.9 Distress

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 0.9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The equity exhibits exceptional capital efficiency with a 33.0% ROIC, indicating robust returns on deployed capital likely driven by the combination of industry-leading gross margins at 80.8% and net margins near 75%. However, the DuPont decomposition suggests this profitability is not solely reliant on high leverage or asset turnover; rather, it reflects a business model with extreme pricing power relative to costs. Financial stability metrics present a dichotomy: while revenue growth of 36.9% YoY signals strong top-line momentum, the Altman Z-Score of 0.9 flags elevated bankruptcy risk, and a Piotroski F-Score of 5/9 indicates moderate financial strength without clear signs of deterioration or improvement in fundamental quality trends.

Valuation metrics suggest significant divergence between current market pricing and intrinsic value models. The stock trades at a forward P/E multiple of 27.3x, which requires scrutiny against historical averages and sector peers to determine if the premium is justified by its growth trajectory. A DCF analysis implies a fair value of $810, suggesting that depending on the current market price relative to this figure, the asset may be either significantly undervalued or priced for perfection given the implied growth assumptions embedded in the model. The market appears willing to pay a substantial premium for the high margin expansion and revenue velocity, potentially pricing in continued acceleration despite the underlying solvency concerns highlighted by the low Z-Score.

The risk-reward profile is characterized by a tension between explosive earnings visibility and structural balance sheet fragility. While the Fama-French alpha data is not provided to assess style exposure, the combination of high leverage implied by the margin structure and the precarious Altman score creates a binary outcome scenario where upside potential from growth could be severely curtailed if liquidity conditions tighten or margins compress. Investors must weigh whether the 36.9% revenue expansion can sustainably offset the distress signals indicated by the Z-Score before concluding that the current valuation multiple offers adequate compensation for these specific tail risks.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$959$740$610
3%$1100$810$650
4%$1311$904$701

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $810 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
0.9
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

80.8%
Gross Margin
74.8%
Net Margin
33.0%
ROIC
+36.9%
Revenue Growth (YoY)
+36.0%
Earnings Growth (YoY)
23.9B
Free Cash Flow
57%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

8.89x
Debt / Equity
1.05x
Current Ratio
5.5x
Interest Coverage
7.95%
FCF Yield
27.4B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $3.29
Act: $3.22
-2.1%
Q3
✓ Beat
Est: $3.25
Act: $3.50
+7.6%
Q2
✓ Beat
Est: $3.75
Act: $3.88
+3.4%
Q1
✓ Beat
Est: $3.01
Act: $3.43
+14.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

25.2
Forward P/E
PEG Ratio
8.31
Price/Book
5M
Avg Volume
$466.00
52W High
$283.20
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in 0388.HK to visualize passive redemption contagion across ETFs and collateral stocks.

0388.HK Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
0388.HKEpicenterEWHETF1299.HKMed Risk0001.HKUnknown2388.HKHigh Risk0016.HKUnknown0669.HKLow Risk
0388.HK Price Drop (%)0

If 0388.HK (0388.HK) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies AIA Group Ltd (1299.HK) as the most exposed collateral stock, sharing 1 ETFs with 0388.HK. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

0388.HK Ownership Dynamics

Ticker
0388.HK

ETFs with Highest 0388.HK Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

0388.HK Capital Efficiency

How efficiently does 0388.HK convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$23.9B
EBITDA
$27.4B
FCF Conversion
87%
Reinvestment Rate
13%
87% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)

0388.HK converts 87% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare 0388.HK to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.